Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Genetics of Parkinson's disease: LRRK2 on the rise.

Brice A.

Brain. 2005 Dec;128(Pt 12):2760-2. No abstract available.

2.

LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.

Krüger R.

BMC Med. 2008 Nov 5;6:33. doi: 10.1186/1741-7015-6-33.

3.

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Berg D, Schweitzer KJ, Leitner P, Zimprich A, Lichtner P, Belcredi P, Brüssel T, Schulte C, Maass S, Nägele T, Wszolek ZK, Gasser T.

Brain. 2005 Dec;128(Pt 12):3000-11. No abstract available.

4.

Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.

Bonifati V.

Eur J Hum Genet. 2006 Oct;14(10):1061-2. Epub 2006 Jul 12. No abstract available.

5.

LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.

Civitelli D, Tarantino P, Nicoletti G, Cirò Candiano IC, Annesi F, De Marco EV, Carrideo S, Rocca FE, Condino F, Spadafora P, Pugliese P, D'Asero S, Morelli M, Paglionico S, Annesi G, Quattrone A.

Clin Genet. 2007 Apr;71(4):367-70. No abstract available.

PMID:
17470139
6.

Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).

Ruiz-Martínez J, Gorostidi A, Ibañez B, Alzualde A, Otaegui D, Moreno F, López de Munain A, Bergareche A, Gómez-Esteban JC, Martí Massó JF.

Mov Disord. 2010 Oct 30;25(14):2340-5. doi: 10.1002/mds.23278.

PMID:
20721916
7.

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.

Carmine Belin A, Westerlund M, Sydow O, Lundströmer K, Håkansson A, Nissbrandt H, Olson L, Galter D.

Mov Disord. 2006 Oct;21(10):1731-4.

PMID:
16817197
8.

High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).

Sierra M, González-Aramburu I, Sánchez-Juan P, Sánchez-Quintana C, Polo JM, Berciano J, Combarros O, Infante J.

Mov Disord. 2011 Nov;26(13):2343-6. doi: 10.1002/mds.23965. Epub 2011 Sep 27.

PMID:
21954089
9.

The genetics of Parkinson disease: to test or not to test.

Suchowersky O.

Can J Neurol Sci. 2007 Aug;34(3):266-7. No abstract available.

PMID:
17803021
10.

Genetics of Parkinson's disease and parkinsonism.

Douglas MR, Lewthwaite AJ, Nicholl DJ.

Expert Rev Neurother. 2007 Jun;7(6):657-66. Review.

PMID:
17563249
11.

Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.

Giordana MT, D'Agostino C, Albani G, Mauro A, Di Fonzo A, Antonini A, Bonifati V.

Mov Disord. 2007 Jan 15;22(2):275-8.

PMID:
17149743
12.
13.

LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.

Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, Burguera JA, Obeso JA, Pastor P.

Mov Disord. 2012 Jan;27(1):146-51. doi: 10.1002/mds.23968. Epub 2011 Oct 28.

PMID:
22038903
14.

Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.

Gosal D, Lynch T, Ross OA, Haugarvoll K, Farrer MJ, Gibson JM.

Mov Disord. 2007 Jan 15;22(2):291-2. No abstract available.

PMID:
17089395
15.

Gait alterations in healthy carriers of the LRRK2 G2019S mutation.

Mirelman A, Gurevich T, Giladi N, Bar-Shira A, Orr-Urtreger A, Hausdorff JM.

Ann Neurol. 2011 Jan;69(1):193-7. doi: 10.1002/ana.22165.

PMID:
21280089
16.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822
17.

Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.

Goldwurm S, Zini M, Mariani L, Tesei S, Miceli R, Sironi F, Clementi M, Bonifati V, Pezzoli G.

Neurology. 2007 Apr 3;68(14):1141-3. Epub 2007 Jan 10.

PMID:
17215492
18.

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.

Brockmann K, Gröger A, Di Santo A, Liepelt I, Schulte C, Klose U, Maetzler W, Hauser AK, Hilker R, Gomez-Mancilla B, Berg D, Gasser T.

Mov Disord. 2011 Nov;26(13):2335-42. doi: 10.1002/mds.23991. Epub 2011 Oct 11.

PMID:
21989859
19.

The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.

Bonifati V.

Curr Neurol Neurosci Rep. 2006 Sep;6(5):355-7. Review. No abstract available.

PMID:
16928343
20.

LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.

Lesage S, Dürr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A; French Parkinson's Disease Genetics Study Group.

N Engl J Med. 2006 Jan 26;354(4):422-3. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk